Our finding that cellular activation by oncogenic PI3K mutant expression or LPS administration changes the extracellular phosphoinositide profile raises the possibility that autocrine/paracrine secretion of phosphoinositides may play a role in the pathogenesis of cancers and inflammatory diseases. This evidence concerns the gene PIK3CA and cancer.